Skip to content
WeighLab

MyDrHank vs AMP Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MyDrHank

Affiliate partner

Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.

Semaglutide / month
$249/moOral, $259/mo injectable (yearly prepay: $171 / $178)
Tirzepatide / month
$349/moMonth-to-month ($240/mo only on a year prepaid)
Index 65/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check MyDrHank pricing Read review

AMP Health

Provider comparison

AMP Health's site is down for maintenance and isn't taking orders.

Semaglutide / month
Not disclosed
Tirzepatide / month
Not disclosed
Unavailable · Not scoredChecked October 2026

AMP Health's site is down for maintenance and isn't taking orders.

Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

This pair includes a provider that is unavailable for direct GLP-1 enrollment. We do not declare a score winner or compare factor scores when either provider is unavailable.

  • AMP Health: AMP Health's site is down for maintenance and isn't taking orders.

Check the difference in state access

MyDrHank
Not published; program excludes KS, LA, MS, NM, ND, WV
AMP Health
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MyDrHank

AMP Health

Semaglutide / month
MyDrHank: $249/moOral, $259/mo injectable (yearly prepay: $171 / $178)
AMP Health: Not disclosed
Tirzepatide / month
MyDrHank: $349/moMonth-to-month ($240/mo only on a year prepaid)
AMP Health: Not disclosed
Semaglutide / year (modeled)
MyDrHank: $2,988
AMP Health: —
Tirzepatide / year (modeled)
MyDrHank: $4,188
AMP Health: —
State availability
MyDrHank: Not published; program excludes KS, LA, MS, NM, ND, WV
AMP Health: Coverage not published
Oral / sublingual option listed
MyDrHank: Yes
AMP Health: Yes
Brand-name access listed
MyDrHank: Not confirmed
AMP Health: Not confirmed
Provider facts checked
MyDrHank: October 2026
AMP Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

Review the access limitations and recorded program details. Availability comes before choosing a treatment plan.

MyDrHank

Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.

Reasons to consider it

  • The price does not change as your dose is titrated up — its FAQ states it plainly ("The price stays the same at every dose — no surprise price increases"), and dose-indexed pricing is the single most common way a cheap first month becomes an expensive fourth one
  • A genuine oral route on semaglutide: a daily tablet, including one compounded with low-dose ondansetron specifically to blunt the nausea that ends most GLP-1 courses early
  • Every plan length is priced in public — monthly, quarterly, 6-month and yearly, with the total for each term printed beside the per-month figure — before any quiz, intake or email capture

What to weigh up

  • EVERY price the site advertises is a twelve-month prepay rate, and not by accident: the price display always shows the cheapest plan, so "From $X/mo" is always the yearly figure. No page shows a month-to-month rate beside it
  • What the twelve months actually cost, up front: oral semaglutide $2,057 to reach the advertised $171/mo, injectable semaglutide $2,140 to reach $178/mo, and tirzepatide $2,883 to reach $240/mo
  • "Plans start at $171/mo with no contract" is the site's own FAQ wording, and its own price list contradicts it — $171 exists only on the Yearly plan. The genuinely no-contract price is $249

Compounded drugs are not FDA-approved. Understand the medication options.

Check MyDrHank pricing Read the full MyDrHank review

AMP Health

AMP Health's site is down for maintenance and isn't taking orders.

Provider background

  • Named founder and clinical lead (Amanda Peyronel, CRNP)
  • Transparent, low consultation fee for the weight-management visit ($100)
  • Offers injectable GLP-1s alongside broader hormone therapy

What to weigh up

  • No actual semaglutide/tirzepatide drug pricing published anywhere on the site
  • Limited to three states (MD, VA, DC) rather than a national telehealth footprint
  • No compounding pharmacy partner named

Regulatory note: the FDA issued a warning letter to Dripgym Mobile Parent, LLC dba Amp Health in February 2026. We still list and link to AMP Health; you should know the letter is on the public record before you decide.

AMP Health's site is down for maintenance and isn't taking orders.

Read the full AMP Health review

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to MyDrHankAlternatives to AMP Health
More provider matchups
CoreAge Rx vs MyDrHankCoreAge Rx vs AMP Health
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.